Alabama sets hearing date for Bristol-Myers Squibb case
Pharma Compliance Alert, July 30, 2008
Alabama Attorney General Troy King successfully prosecuted AstraZeneca, GlaxoSmithKline, and Novartis for price fraud. Next up: Bristol-Myers Squibb (BMS).
Montgomery County Circuit Judge Charles Price set an October trial date for the case against BMS, according to an Associated Press article. Abbott Laboratories and Sandoz, a Novartis subsidiary, were scheduled to go to trial with BMS, but Price delayed those trials.
King filed suit against 73 pharmaceutical companies in 2005, claiming the companies illegally inflated prices. In February, a jury found AstraZeneca guilty of fraud. In July, a separate jury found Novartis and GlaxoSmithKline guilty of defrauding Medicaid, but awarded compensatory damages without punitive damages. AstraZeneca had its judgment reduced when it appealed the case. Novartis and GlaxoSmithKline plan to appeal their verdicts.
Two pharmaceutical companies, Dey and Takeda Pharmaceuticals, collectively agreed to pay $6.75 million to settle with the state.
Comments
0 comments on “Alabama sets hearing date for Bristol-Myers Squibb case ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched